Wednesday, July 24, 2024

Quantification of the content of cannabinol in commercially available e-liquids and studies on their thermal and photo-stability

Share


  • 1.

    ElSohly, M. & Gul, W. Constituents of cannabis sativa. In Handbook of cannabis (ed. Pertwee, R.) 3–22 (Oxford University Press, 2014).

  • 2.

    Wright, S. & Metts, J. Recreational cannabinoid use: the hazards behind the “high”. J. Fam. Pract. 65(11), 770–776 (2016).

    PubMed 

    Google Scholar 

  • 3.

    Grotenhermen, F. Cannabis and Cannabinoids-Pharmacology, Toxicology, and Therapeutic Potential (eds Grotenhermen, F. & Russo, E.) 55–65 (Haworth Press, 2002).

  • 4.

    Pertwee, R. G. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br. J. Pharmacol. 153(2), 199–215 (2008).

    CAS 
    Article 

    Google Scholar 

  • 5.

    Adams, R., Hunt, M. & Clark, J. H. Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp. J. Am. Chem. Soc. 62(1), 196–200 (1940).

    CAS 
    Article 

    Google Scholar 

  • 6.

    Consroe, P. Brain cannabinoid systems as targets for the therapy of neurological disorders. Neurobiol. Dis. 5(6), 534–551 (1998).

    CAS 
    Article 

    Google Scholar 

  • 7.

    Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V. & Mechoulam, R. Cannabinoidi vegetali non psicotropi: nuove opportunità terapeutiche da un’erba antica. Trends Pharmacol. Sci. 30, 515–527 (2009).

    CAS 
    Article 

    Google Scholar 

  • 8.

    McPartland, J. M. & Russo, E. B. Cannabis and cannabis extracts: greater than the sum of their parts? J. Cannabis Ther. 1(3-4), 103–132 (2001).

    CAS 
    Article 

    Google Scholar 

  • 9.

    Mechoulam, R., Parker, L. A. & Gallily, R. Cannabidiol: an overview of some pharmacological aspects. J. Clin. Pharmacol. 42(S1), 11S–19S (2002).

    CAS 
    Article 

    Google Scholar 

  • 10.

    Mechoulam, R. & Hanuš, L. Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects. Chem. Phys. Lipids 121(1-2), 35–43 (2002).

    CAS 
    Article 

    Google Scholar 

  • 11.

    Laprairie, R. B., Bagher, A. M., Kelly, M. E. M. & Denovan-Wright, E. M. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br. J. Pharmacol. 172(20), 4790–4805 (2015).

    CAS 
    Article 

    Google Scholar 

  • 12.

    Hawksworth, G. & McArdle, K. Metabolism and pharmacokinetics of cannabinoids. In The Medicinal Uses of Cannabis and Cannabinoids (eds. Guy, G.W., Whittle, B.A. & Robson, P.J.) 205–228 (Pharmaceutical Press: London 2004).

  • 13.

    Fasinu, P. S., Phillips, S., ElSohly, M. A. & Walker, L. A. Current status and prospects for cannabidiol preparations as new therapeutic agents. Pharmacotherapy 36(7), 781–796 (2016).

    Article 

    Google Scholar 

  • 14.

    Ohlsson, A. et al. Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biomed. Environ. Mass. Spectrom. 13(2), 77–83 (1986).

    CAS 
    MathSciNet 
    Article 

    Google Scholar 

  • 15.

    Iffland, K. & Grotenhermen, F. An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies. Cannabis Cannabinoid Res. 2(1), 139–154 (2017).

    CAS 
    Article 

    Google Scholar 

  • 16.

    Eggers, M. E. et al. Youth use of electronic vapor products and blunts for administering cannabis. Addict. behav. 70, 79–82 (2017).

    Article 

    Google Scholar 

  • 17.

    de Lacy, E., Fletcher, A., Hewitt, G., Murphy, S. & Moore, G. Cross-sectional study examining the prevalence, correlates and sequencing of electronic cigarette and tobacco use among 11–16-year olds in schools in Wales. BMJ open, 7(2), e012784 (2017).

    Article 

    Google Scholar 

  • 18.

    Electronic Nicotine Delivery Systems. (World Health Organisation (WHO) Framework Convention on Tobacco Control, 2014).

  • 19.

    Ogunwale, M. A. et al. Aldehyde detection Electron. Cigar. aerosols. ACS omega 2(3), 1207–1214 (2017).

    CAS 

    Google Scholar 

  • 20.

    Kosmider, L. et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob. Res. 16(10), 1319–1326 (2014).

    CAS 
    Article 

    Google Scholar 

  • 21.

    Warning Letters and Test Results. (United States Food and Drug Administration, 2015b).

  • 22.

    Peace, M. R., Butler, K. E., Wolf, C. E., Poklis, J. L. & Poklis, A. Evaluation of two commercially available cannabidiol formulations for use in electronic cigarettes. Front. Pharmacol. 7, 279 (2016).

    Article 

    Google Scholar 

  • 23.

    Warning letters and test results for cannabidiol-related products. (US Food and Drug Administration, 2017).

  • 24.

    Trofin, I. G., Dabija, G., Vaireanu, D. I. & Filipescu The influence of long-term storage conditions on the stability of cannabinoids derived from cannabis resin. Rev. Chim. Buchar. 63(4), 422–427 (2012).

    CAS 

    Google Scholar 

  • 25.

    USP 26: The United States Pharmacopeia: 26. Rev.; NF 21: the National Formulary: 21. Ed. Supplement (USPC, 2003).

  • 26.

    Bonn-Miller, M. O. et al. Labeling accuracy of cannabidiol extracts sold online. Jama 318(17), 1708–1709 (2017).

    Article 

    Google Scholar 

  • 27.

    Data provided by Brightfieldgroup.



  • Source link

    Subscribe
    Notify of
    guest

    0 Comments
    Inline Feedbacks
    View all comments

    Read more

    Search more

    Latest News